↓ Skip to main content

Dove Medical Press

Luteolin Attenuates Atherosclerosis Via Modulating Signal Transducer And Activator Of Transcription 3-Mediated Inflammatory Response

Overview of attention for article published in Drug Design, Development and Therapy, November 2019
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (74th percentile)
  • High Attention Score compared to outputs of the same age and source (84th percentile)

Mentioned by

news
1 news outlet

Citations

dimensions_citation
40 Dimensions

Readers on

mendeley
14 Mendeley
Title
Luteolin Attenuates Atherosclerosis Via Modulating Signal Transducer And Activator Of Transcription 3-Mediated Inflammatory Response
Published in
Drug Design, Development and Therapy, November 2019
DOI 10.2147/dddt.s207185
Pubmed ID
Authors

Xiaoji Ding, Lulu Zheng, Bo Yang, Xiaodong Wang, Yin Ying

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 14 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 14 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 2 14%
Professor 1 7%
Student > Ph. D. Student 1 7%
Unspecified 1 7%
Student > Postgraduate 1 7%
Other 1 7%
Unknown 7 50%
Readers by discipline Count As %
Pharmacology, Toxicology and Pharmaceutical Science 3 21%
Unspecified 1 7%
Biochemistry, Genetics and Molecular Biology 1 7%
Agricultural and Biological Sciences 1 7%
Medicine and Dentistry 1 7%
Other 0 0%
Unknown 7 50%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 7. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 13 February 2023.
All research outputs
#4,947,179
of 25,806,080 outputs
Outputs from Drug Design, Development and Therapy
#312
of 2,283 outputs
Outputs of similar age
#93,751
of 379,599 outputs
Outputs of similar age from Drug Design, Development and Therapy
#4
of 32 outputs
Altmetric has tracked 25,806,080 research outputs across all sources so far. Compared to these this one has done well and is in the 79th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,283 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.3. This one has done well, scoring higher than 84% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 379,599 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 74% of its contemporaries.
We're also able to compare this research output to 32 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 84% of its contemporaries.